Thomas Ebeling
Christof Stache/AP/REX/Shutterstock

ProSiebenSat.1 Media



Since joining ProSiebenSat.1, Ebeling has overseen wide-ranging restructuring, including divestment of TV and radio stations outside the German-speaking region and development of the digital division. In March 2016, the group became the first media company to ever be included in Deutsche Börse’s blue chip DAX index.

The conglomerate’s vast media holdings include its core advertising-financed free-TV channels as well as pay outlets, the Red Arrow Entertainment production and global sales unit and the growing digital division.

Ebeling has said he plans to introduce an additional business model before he steps down in February 2018. As part of the group’s continuing efforts to increase non-advertising revenue, ProSiebenSat.1 will seek to market its own products by advertising them on its channels and distributing them in stores. Possible products include vegan snacks, organic cosmetics and weight loss and diet items.

Before his appointment as ProSiebenSat.1’s chief executive in 2009, Ebeling served as CEO of the global Novartis pharmaceuticals business from 2000 to 2007.


  • ProSiebenSat.1 Media
  • Rantum Capital Management
  • Novartis Pharma AG


  • University of Hamburg (Germany)

Variety Honors

  • 2017 Variety500 Honoree
Interested in org charts, contact info and more for Thomas Ebeling

News from Variety

Thomas Ebeling to Step Down as Head of Germany's ProSiebenSat.1

Thomas Ebeling to Step Down as Head of Germany's ProSiebenSat.1

The hunt is on for a new chief of one of Europe's biggest media companies after Thomas Ebeling, the boss of Germany's ProSiebenSat.1, said he will leave the company on Feb. 22, 2018. Ebeling had previously indicated his intention to move on and has now fixed his exit for directly after the company's February press conference on its FY2017 results.The departing chief’s contract ran until mid-2019, but he told German press late last year that he did not want to...


Want more information on Thomas Ebeling?

Sign up for a free trial to view Thomas's credits, company details, production deals, & more